Biosimilars Market size was valued at USD 25.10 Billion in 2022 and is expected to reach USD 91.81 Billion By 2030 and grow at a CAGR of 17.6% over the forecast period of 2023-2030. This impressive surge is driven by a confluence of factors, including: Significant cost savings: Biosimilars, highly similar versions of existing biologic drugs, offer substantial cost...

The global animal healthcare market is estimated at US$ 42.87 billion in 2024, as per a new study by Fact.MR. Worldwide demand for animal health products is forecasted to increase at a CAGR of 4.6% and reach a market value of US$ 67.48 billion by the end of 2034. The global animal healthcare market has witnessed significant growth in recent years, driven by various factors such as the...

Biosimilars Market Scope According to Market Research Future (MRFR), the biosimilars market research report has valued the industry at USD 24.38 billion in 2021 and is projected to grow from USD 28.13 Billion in 2022 to USD 95.00 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 23.90% during the forecast period (2022 - 2030). Biosimilars Market: Latest News and...

Blood Collection Device Market is expected to reach US$ 8.25 Bn. at a CAGR of 6.78% during the forecast period 2029. Blood Collection Device Market Overview Over the forecast period, Maximize Market Research expects the Blood Collection Device Market growth from USD in 2022 to USD in 2029 at a CAGR of percent. The report analyzed by Maximize Market Research, on...

The global blood collection devices market is poised to grow at a CAGR of 6.8% over the next five years to reach $8.42 billion by 2027, according to a recent report by MarketsandMarkets. The growth is being fueled by a rising number of blood transfusions, donations, and disorders that require blood draws for diagnosis or treatment. However, the market does face headwinds such as a lack of...

Roots Analysis has done a detailed study on “Cell and Gene Therapy CROs Market, 2022-2035”, covering key aspects of the industry’s evolution and identifying potential future growth opportunities.   Key Market Insights More than 105 CROs claim to provide a wide range of preclinical and clinical services for the development of advanced therapy medicinal products. The...

The Biosimilars Market is experiencing a surge in growth, driven by the increasing popularity of generic biologics. These biologics, also known as biosimilars, offer cost-effective alternatives to branded biologic drugs, providing patients with access to high-quality treatments at reduced prices. The development of generic biologics involves a rigorous process to demonstrate similarity to the...

Large volume wearable injectors market was valued at US$ 1471 million in 2023 and is expected to reach US$ 11290 million by 2030, growing at a CAGR of 33.4% during the forecast period (2024-2030). This rapid growth is attributed to the increasing prevalence of chronic diseases, rising demand for self-administered treatments, and technological advancements in injector design. Wearable injectors...

The Medical Second Opinion Market size was valued at USD 5457.65 million in 2022 and is expected to grow to USD 17046.70 million by 2030 and grow at a CAGR of 15.3% over the forecast period of 2023-2030. Key Drivers of Market Expansion: Patient Empowerment: Growing awareness of healthcare options and access to medical information empower patients to seek second opinions for...